发明名称 |
PHARMACEUTICAL COMPOSITIONS COMPRISING 2-METHOXY-5- (5-TRIFLUOROMETHYL-TETRAZOL-I-YL-BENZYL) - (2S-PHENYL-PIPERIDIN-3S-YL-) |
摘要 |
<p>The present invention relates to pharmaceutical compositions comprising the NK1 receptor antagonist [2-Methoxy-5-(5-trifuoromethyl-tetrazol-1-yl)-benzyl]-(2S-phenyl- piperidin-3S-yl)-amine, or a pharmaceutically acceptable salt or solvate thereof, and a sodium channel blocker, as a combined preparation for simultaneous or sequential administration and to the use of such compositions in the treatment of certain disorders, including epilepsy, mood disorders and pain.</p> |
申请公布号 |
WO2008090114(A1) |
申请公布日期 |
2008.07.31 |
申请号 |
WO2008EP50621 |
申请日期 |
2008.01.21 |
申请人 |
GLAXO GROUP LIMITED;ALVARO, GIUSEPPE;LARGE, CHARLES |
发明人 |
ALVARO, GIUSEPPE;LARGE, CHARLES |
分类号 |
A61K31/41;A61P25/00;A61P25/08;A61P25/22;A61P25/24 |
主分类号 |
A61K31/41 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|